Just like the 2020 resolution, Novartis AG’s $twenty five million 2016 civil resolution Along with the SEC involved poor sponsorships of HCPs to conferences and inappropriate payments to HCPs to gather “health-related information.” The point that Novartis has become dealing with a considerably greater—and criminal—resolution for related m